Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated clostridium difficile infection (CDI) within a retrospective cohort

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Stevens, Vanessa ^a   Concannon, Cathleen ^b   van Wijngaarden, Edwin ^b   McGregor, Jessina ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic disease score; Clostridium difficile infection; Comorbidity score; Infectious disease (CDS ID); Validation

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; CALIBRATION; CHRONIC DISEASE SCORE INFECTIOUS DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; RETROSPECTIVE STUDY; SCORING SYSTEM; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CLINICAL MEDICINE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84875301676     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-150     Document Type: Article

References (32)

1. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 2002, 23(11):653-659.
2. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998, 40(1):1-15. 10.1016/S0195-6701(98)90019-6, 9777516.
3. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE, Committee SL-T-C. Clostridium difficile in long-term-care facilities for the elderly. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 2002, 23(11):696-703.
4. Vesta KS, Wells PG, Gentry CA, Stipek WJ. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Am J Infect Control 2005, 33(8):469-472. 10.1016/j.ajic.2005.06.004, 16216661.
5. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990, 162(3):678-684. 10.1093/infdis/162.3.678, 2387993.
6. Nelson DE, Auerbach SB, Baltch AL, Desjardin E, Beck-Sague C, Rheal C, Smith RP, Jarvis WR. Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 1994, 15(2):88-94.
7. Babyak MA. What You See May Not Be what You Get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine 2004, 66(3):411-421. 10.1097/01.psy.0000127692.23278.a9, 15184705.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. 10.1016/0021-9681(87)90171-8, 3558716.
9. Horn SD, Chachich B, Clopton C. Measuring severity of illness: a reliability study. Med Care 1983, 21(7):705-714. 10.1097/00005650-198307000-00004, 6888027.
10. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology 1992, 45(2):197-203. 10.1016/0895-4356(92)90016-G, 1573438.
11. Labbé A-C, Poirier L, MacCannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J. Clostridium difficile infections in a canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008, 52(9):3180-3187. 10.1128/AAC.00146-08, 2533448, 18573937.
12. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann M-C, Harris AD. Utility of the chronic disease score and charlson comorbidity index as comorbidity measures for Use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005, 161(5):483-493. 10.1093/aje/kwi068, 15718484.
13. McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006, 59(12):1266-1273. 10.1016/j.jclinepi.2006.01.016, 17098569.
14. Charlson ME, Ales KL, Simon R, MacKenzie CR. Why predictive indexes perform less well in validation studies: is It magic or methods?. Arch Intern Med 1987, 147(12):2155-2161. 10.1001/archinte.1987.00370120091016, 3689067.
15. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000, 29(5):891-898. 10.1093/ije/29.5.891, 11034974.
16. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of clostridium difficile infection. Clin Infect Dis 2011, 53(1):42-48. 10.1093/cid/cir301, 21653301.
17. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Ad Hoc clostridium difficile surveillance working G: recommendations for surveillance of clostridium difficile-associated disease. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 2007, 28(2):140-145.
18. Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's the pharmacological basis of therapeutics 2006, New York: McGraw-Hill, Volume 11th.
19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44(3):837-845. 10.2307/2531595, 3203132.
20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143(1):29-36.
21. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982, 115(1):92-106.
22. Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the hosmer-lemeshow test revisited. Crit Care Med 2007, 35(9):2052-2056. 10.1097/01.CCM.0000275267.64078.B0, 17568333.
23. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007, 45(12):1543-1549. 10.1086/523582, 18190314.
24. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA: the journal of the American Medical Association 2005, 294(23):2989-2995.
25. Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V. Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile-associated diarrhea: a cohort study during an epidemic in quebec. Clin Infect Dis 2005, 41(9):1254-1260. 10.1086/496986, 16206099.
26. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 1990, 11(6):283-290.
27. Dial S, Delaney JAC, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. Canadian Medical Association journal 2006, 175(7):745-748. 10.1503/cmaj.060284, 1569908, 17001054.
28. Stevens V, Dumyati G, Brown J, van Wijngaarden E. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiology and Drug Safety 2011, 20(10):1035-1042. 10.1002/pds.2198, 21833992.
29. Akkerman AE, van der Wouden JC, Kuyvenhoven MM, Dieleman JP, Verheij TJM. Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother 2004, 54(6):1116-1121. 10.1093/jac/dkh480, 15546973.
30. Junior M, Correa L, Marra A, Camargo L, Pereira C. Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infect Dis 2007, 7(1):88. 10.1186/1471-2334-7-88, 2014772, 17678541.
31. McCarthy DM. Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?. J Clin Gastroenterol 2012, 46(5):350-353. 10.1097/MCG.0b013e31824b228f, 22495812.
32. Schmidt ML, Gilligan PH. Clostridium difficile testing algorithms: what is practical and feasible?. Anaerobe 2009, 15(6):270-273. 10.1016/j.anaerobe.2009.10.005, 19853666.